Real-life outcomes on acute promyelocytic leukemia in Brazil–Early deaths are still a problem
WF da Silva Jr, LI da Rosa, GL Marquez… - … Myeloma and Leukemia, 2019 - Elsevier
Introduction Although a considerable improvement in survival of patients with acute
promyelocytic leukemia (APL) has been seen over the past decades, real-life outcomes …
promyelocytic leukemia (APL) has been seen over the past decades, real-life outcomes …
The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study
M Baysal, V Gürsoy, FC Hunutlu, B Erkan… - Annals of …, 2022 - Springer
Acute promyelocytic leukemia (APL) differs from other forms of acute myeloid leukemia
(AML), including coagulopathy, hemorrhage, disseminated intravascular coagulation (DIC) …
(AML), including coagulopathy, hemorrhage, disseminated intravascular coagulation (DIC) …
Current first-and second-line treatment options in acute promyelocytic leukemia
Outcome of acute promyelocytic leukemia (APL) has remarkably improved during the last 30
years, especially after the identification of PML–RARA oncogene as a key in the …
years, especially after the identification of PML–RARA oncogene as a key in the …
[HTML][HTML] Blood parameters in treatment with arsenic trioxide in acute promyelocytic leukemia: A systematic review
MM Kanesbi, L Jarahi, MR Keramati - International Journal of …, 2020 - ncbi.nlm.nih.gov
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML). APL is
famed with some special blood coagulation disorders such as disseminated intravascular …
famed with some special blood coagulation disorders such as disseminated intravascular …
初发急性早幼粒细胞白血病患者五项凝血指标的临床意义
马黎丽， 王卫国， 张夏， 王伟伟， 黄传荣 - 临床输血与检验, 2018 - lcsxyjy.com
目的分析初诊急性早幼粒细胞白血病(APL) 五项凝血指标的变化, 初步探讨异常指标检测的临床
意义. 方法采用Sysmex 血凝仪检测46 例初诊APL 患者(其中高危18 例, 中低危28 例; 12 …
意义. 方法采用Sysmex 血凝仪检测46 例初诊APL 患者(其中高危18 例, 中低危28 例; 12 …
[HTML][HTML] Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia: An Experience From a Resource-Constraint Country
W Thakur, N Anwar, N Fatima, A Jamal, QA Rizvi… - Cureus, 2022 - ncbi.nlm.nih.gov
Results A total of 85 APML patients were registered at our institute. Among them, 62 (73%)
were included in the analysis as per the inclusion criteria of the study. The median age was …
were included in the analysis as per the inclusion criteria of the study. The median age was …
[HTML][HTML] Usefulness of two clinical (CBC and PETHEMA) scores for predicting early death in patients with acute promyelocytic leukemia: A single-center study in …
CO Ramos-Peñafiel, E Montaño-Figueroa… - Revista médica del …, 2019 - scielo.org.mx
Resumen RAMOS-PENAFIEL, Christian O. et al. Usefulness of two clinical (CBC and
PETHEMA) scores for predicting early death in patients with acute promyelocytic leukemia …
PETHEMA) scores for predicting early death in patients with acute promyelocytic leukemia …
Clinical Significance of Five Coagulation Markers in Patients with Acute Promyelocytic Leukemia
W MALi-li, Z Xia - JOURNAL OF CLINICAL TRANSFUSION AND …, 2018 - lcsxyjy.com
Objective To analyze the changes of five blood coagulation indexes and exploretheir clinical
significance inpatients with acute promyelocytic leukemia (APL). Methods Prothrombin time …
significance inpatients with acute promyelocytic leukemia (APL). Methods Prothrombin time …
Значај Одређивања Нивоа Експресије Вилмсовог Туморског Гена 1 код Педијатријских Пацијената са Акутном Леукемијом
СJ Јанковић - 2016 - search.proquest.com
Акутне дечје леукемије су група обољења која представља најчешће малигне болести
дечјег доба. Одликују се блокадом диференцијације и неконтролисаном …
дечјег доба. Одликују се блокадом диференцијације и неконтролисаном …